Vizionfocus Inc.

TWSE:4771 Stock Report

Market Cap: NT$10.1b

Vizionfocus Valuation

Is 4771 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Future Cash Flow Value

  • Significantly Below Future Cash Flow Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Future Cash Flow Value

What is the Fair Price of 4771 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Future Cash Flow Value: 4771 (NT$179) is trading below our estimate of future cash flow value (NT$1484.76)

Significantly Below Future Cash Flow Value: 4771 is trading below future cash flow value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 4771?

Key metric: As 4771 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 4771. This is calculated by dividing 4771's market cap by their current earnings.
What is 4771's PE Ratio?
PE Ratio14.9x
EarningsNT$704.51m
Market CapNT$10.13b

Price to Earnings Ratio vs Peers

How does 4771's PE Ratio compare to its peers?

The above table shows the PE ratio for 4771 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average19.6x
4129 United Orthopedic
18.2xn/aNT$10.0b
6782 Visco Vision
13.6x13.34%NT$11.6b
4107 Bioteque
16.1xn/aNT$8.2b
1786 SciVision Biotech
30.8xn/aNT$4.9b
4771 Vizionfocus
14.9xn/aNT$10.1b

Price-To-Earnings vs Peers: 4771 is good value based on its Price-To-Earnings Ratio (14.9x) compared to the peer average (19.6x).

Historical Price to Earnings Ratio

Historical Price to Earnings Ratio compares a stock's price to its earnings over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Earnings Ratio vs Industry

How does 4771's PE Ratio compare vs other companies in the TW Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
4771 14.9xIndustry Avg. 18.0xNo. of Companies7PE01224364860+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 4771 is good value based on its Price-To-Earnings Ratio (14.9x) compared to the TW Medical Equipment industry average (18x).

Price to Earnings Ratio vs Fair Ratio

What is 4771's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

4771 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio14.9x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 4771's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 4771 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentNT$179.00
NT$231.33
+29.24%
5.66%NT$248.00NT$216.00n/a3
Feb ’27NT$175.00
NT$226.00
+29.14%
3.15%NT$232.00NT$216.00n/a3
Jan ’27NT$173.00
NT$226.00
+30.64%
3.15%NT$232.00NT$216.00n/a3
Dec ’26NT$180.00
NT$224.50
+24.72%
2.98%NT$232.00NT$216.00n/a4
Nov ’26NT$179.50
NT$225.50
+25.63%
3.73%NT$238.00NT$216.00n/a4
Oct ’26NT$178.50
NT$233.75
+30.95%
9.38%NT$271.00NT$216.00n/a4
Sep ’26NT$182.00
NT$233.75
+28.43%
9.38%NT$271.00NT$216.00n/a4
Aug ’26NT$180.00
NT$233.75
+29.86%
9.38%NT$271.00NT$216.00n/a4
Jul ’26NT$179.50
NT$239.67
+33.52%
9.34%NT$271.00NT$220.00n/a3
Jun ’26NT$209.00
NT$239.67
+14.67%
9.34%NT$271.00NT$220.00n/a3
May ’26NT$200.50
NT$231.67
+15.54%
12.33%NT$271.00NT$204.00n/a3
Apr ’26NT$210.00
NT$234.50
+11.67%
4.05%NT$244.00NT$225.00n/a2
Mar ’26NT$194.00
NT$264.50
+36.34%
14.93%NT$304.00NT$225.00NT$181.002
Feb ’26n/a
NT$259.50
0%
17.15%NT$304.00NT$215.00NT$175.002
Jan ’26NT$168.50
NT$259.50
+54.01%
17.15%NT$304.00NT$215.00NT$173.002
Dec ’25NT$185.00
NT$259.50
+40.27%
17.15%NT$304.00NT$215.00NT$180.002
Nov ’25NT$201.00
NT$287.50
+43.03%
5.74%NT$304.00NT$271.00NT$179.502
Oct ’25NT$233.50
NT$287.50
+23.13%
5.74%NT$304.00NT$271.00NT$178.502
NT$231.33
Fair Value
22.6% undervalued intrinsic discount
3
Number of Analysts

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/03/05 11:32
End of Day Share Price 2026/03/05 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Vizionfocus Inc. is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jianzheng WuCapital Securities Corporation
Angus ChuangKGI Securities Co. Ltd.
Hsiu Chi LinMasterlink Securities Corp.